Skip to content
RxLibra
  • Home
  • NEWS
    • NewsRoom
    • TradeKown
    • PRsources
  • Community
  • Product
    • PIPELINE
    • MITODX
  • About
    • FSDL
    • Contact
  • Copyright
RxLibra
  • Home
  • NEWS
    • NewsRoom
    • TradeKown
    • PRsources
  • Community
  • Product
    • PIPELINE
    • MITODX
  • About
    • FSDL
    • Contact
  • Copyright

Categories:

NEWs

2025 Make cost-effectiveness more accessible in Southeast Asian

RxLibra /
December 6, 2024 /
0 comment(s)
December, 06, 2024(Vientiane)After nearly three years of development from 2022 to 2024, RxLibra has helped Lao pharmaceutical industry open the door to the international market. The following is our record of commitment to the industry and our clients […]
read more
Recent Posts
  • 2025 Make cost-effectiveness more accessible in Southeast Asian
  • Double “0” breakthrough! Laos BIGBEAR Pharmaceutical’s anti-cancer drugs are exported to ASEAN economies for the first time
  • How to quote for international trade?
  • RxLibra P2P Exchange Community-Recruit community members
  • How to inquire about the product registration information of Lao pharmaceutical companies?
Recent Comments
    Archives
    • December 2024
    • September 2024
    • March 2024
    • February 2024
    • August 2023
    • October 2022
    • September 2022
    • August 2022
    • June 2022
    • May 2022
    Categories
    • NEWs
    • PIPELINE
    • TradeKown
    © 2025 RxLibra. Created for free using WordPress and Colibri